139 related articles for article (PubMed ID: 11863411)
1. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer.
Zhang L; Adams JY; Billick E; Ilagan R; Iyer M; Le K; Smallwood A; Gambhir SS; Carey M; Wu L
Mol Ther; 2002 Mar; 5(3):223-32. PubMed ID: 11863411
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
Iyer M; Salazar FB; Lewis X; Zhang L; Carey M; Wu L; Gambhir SS
Mol Ther; 2004 Sep; 10(3):545-52. PubMed ID: 15336654
[TBL] [Abstract][Full Text] [Related]
3. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y; Maitani Y
Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
[TBL] [Abstract][Full Text] [Related]
4. Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.
Watanabe M; Ueki H; Ochiai K; Huang P; Kobayashi Y; Nasu Y; Sasaki K; Kaku H; Kashiwakura Y; Kumon H
Oncol Rep; 2011 Oct; 26(4):769-75. PubMed ID: 21725614
[TBL] [Abstract][Full Text] [Related]
5. Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.
Dzojic H; Cheng WS; Essand M
Cancer Gene Ther; 2007 Mar; 14(3):233-40. PubMed ID: 17053814
[TBL] [Abstract][Full Text] [Related]
6. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
[TBL] [Abstract][Full Text] [Related]
7. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.
Iyer M; Wu L; Carey M; Wang Y; Smallwood A; Gambhir SS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14595-600. PubMed ID: 11734653
[TBL] [Abstract][Full Text] [Related]
8. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
[TBL] [Abstract][Full Text] [Related]
9. Indirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy.
Chen IY; Gheysens O; Ray S; Wang Q; Padmanabhan P; Paulmurugan R; Loening AM; Rodriguez-Porcel M; Willmann JK; Sheikh AY; Nielsen CH; Hoyt G; Contag CH; Robbins RC; Biswal S; Wu JC; Gambhir SS
Gene Ther; 2010 Jul; 17(7):827-38. PubMed ID: 20237511
[TBL] [Abstract][Full Text] [Related]
10. Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression.
Ray S; Paulmurugan R; Hildebrandt I; Iyer M; Wu L; Carey M; Gambhir SS
Hum Gene Ther; 2004 Jul; 15(7):681-90. PubMed ID: 15242528
[TBL] [Abstract][Full Text] [Related]
11. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
12. Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression.
Woraratanadharm J; Rubinchik S; Yu H; Dong JY
BMC Biotechnol; 2007 Feb; 7():9. PubMed ID: 17295927
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.
Iyer M; Salazar FB; Lewis X; Zhang L; Wu L; Carey M; Gambhir SS
Transgenic Res; 2005 Feb; 14(1):47-55. PubMed ID: 15865048
[TBL] [Abstract][Full Text] [Related]
14. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
Wu L; Matherly J; Smallwood A; Adams JY; Billick E; Belldegrun A; Carey M
Gene Ther; 2001 Sep; 8(18):1416-26. PubMed ID: 11571582
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy.
Segawa T; Takebayashi H; Kakehi Y; Yoshida O; Narumiya S; Kakizuka A
Cancer Res; 1998 Jun; 58(11):2282-7. PubMed ID: 9622059
[TBL] [Abstract][Full Text] [Related]
17. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
Yu DC; Sakamoto GT; Henderson DR
Cancer Res; 1999 Apr; 59(7):1498-504. PubMed ID: 10197620
[TBL] [Abstract][Full Text] [Related]
18. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
